Delivery Order SPE2DX22D0049-SPE2D825FB0VX
- Not listed
- This delivery order, valued at $47,986.56, was awarded on August 27, 2025, to AmerisourceBergen Drug Corp (CAGE 0U9U0), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract employs firm fixed price terms and has a completion date of August 28, 2025. The award was made competitively with no set-aside designation and is funded by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal procurement entity. This delivery order...
- This delivery order, valued at $3,270.81, was awarded on September 3, 2025, to AmerisourceBergen Drug Corp (CAGE 0U9U0) by the Defense Logistics Agency's Medical Supply Chain division under a firm fixed-price contract with a completion date of September 4, 2025. The award represents a child contract—a specific task order issued under a larger indefinite delivery vehicle. AmerisourceBergen maintains a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX)...
- This delivery order, valued at $1,840.50, was awarded on September 8, 2025, to AmerisourceBergen Drug Corp (CAGE 0U9U0) by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency. The contract is classified as a firm fixed price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen will perform work at its corporate office location in Conshohocken, Pennsylvania, with a completion deadline of September 9, 2025. This delivery...
- This delivery order, valued at $30,969.00, was awarded on August 19, 2025, to AmerisourceBergen Drug Corp (CAGE 0U9U0), the prime contractor, under a firm fixed price arrangement with an ultimate completion date of August 20, 2025. The contract is funded by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency responsible for pharmaceutical and medical supply procurement for military and veteran healthcare systems. This is a non-set-aside, competitively awarded...
- This delivery order, valued at $7,555.50, was awarded to AmerisourceBergen Drug Corp on August 20, 2025, under a firm fixed price contract with the Defense Logistics Agency Medical Supply Chain, a defense-focused federal agency. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion comprehensive pharmaceutical support vehicle running through December 2026. This delivery order was...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $10,447.93 from the Defense Logistics Agency's Medical Supply Chain on September 8, 2025. This firm fixed-price delivery order, with an ultimate completion date of September 9, 2025, was awarded without set-aside designation through competitive procedures. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- This delivery order, valued at $17,342.69 and awarded on September 8, 2025, was issued to AmerisourceBergen Drug Corp under a firm fixed-price arrangement with an ultimate completion date of September 9, 2025. The contract was competitively awarded with no set-aside designation to support the Defense Logistics Agency's Medical Supply Chain, which procures pharmaceutical products and medical supplies for military and veteran healthcare systems. AmerisourceBergen, headquartered in Conshohocken,...
- This delivery order, valued at $31,274.68 and awarded September 1, 2025, was issued to AmerisourceBergen Drug Corp (CAGE 0U9U0) under a firm fixed-price arrangement with an ultimate completion date of September 2, 2025. The contract is a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The funding agency is the Medical Supply Chain, which operates...
- This delivery order, valued at $1,032.82, was awarded to AmerisourceBergen Drug Corp on August 14, 2025, under a Defense Logistics Agency contract for pharmaceutical and medical supply procurement. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract utilizes firm fixed pricing with no set-aside designation, indicating...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for pharmaceutical and medical supplies. This delivery order, valued at $1,833.80, represents a firm fixed price contract with an ultimate completion date of August 12, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was selected through competitive procurement without set-aside designation. The award functions as a child contract...
- SPE2DX22D0049Indefinite Delivery Contract
- SPE2DX22D0049-SPE2D825FB0VXDelivery Order
This delivery order, valued at $30,571.10, was awarded on September 8, 2025, to AmerisourceBergen Drug Corp (CAGE 0U9U0) under a firm fixed-price arrangement with an ultimate completion date of September 9, 2025. The contract is funded by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency responsible for pharmaceutical and medical supply procurement for military and veteran healthcare systems. This non-set-aside award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The prime contractor is headquartered in Conshohocken, Pennsylvania, where the place of performance is also located. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor, supplying an extensive portfolio of pharmaceutical products and medical supplies including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's SPE2DX vehicle functions as a comprehensive global pharmaceutical support contract enabling supply of critical medical commodities to support military healthcare programs worldwide. As the DLA Troop Support Medical transitions to Pharmaceutical Prime Vendor Global Program Generation V contracts with planned multiple regional awards, AmerisourceBergen Drug Corp continues to serve Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its established contract vehicles and demonstrated capability to meet federal procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $30.6k | 9/8/25 |